SAN DIEGO – Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI), identified for supplying reagents and companies to the life science analysis and biotechnology sectors, has indicated its anticipated complete income for the fiscal 12 months 2024.
Shares fell 5% in after-hours commerce Wednesday.
The corporate’s preliminary year-end outcomes, that are topic to plain year-end changes, counsel that its income is anticipated to align with the mid-point of its beforehand forecasted vary of $255 million to $265 million.
This projection is positioned within the neighborhood of the consensus estimate, which predicts a fiscal 12 months income of roughly $260.78 million.
This text was generated with the help of AI and reviewed by an editor. For extra info see our T&C.
Fears of a US-EU commerce conflict have been reignited after Europe refused to again down…
President Trump's Friday flurry of pronouncements marks the return of negotiation by smartphone and will…
The British-born newspaper-owner whose takeover of The Each day Telegraph seems to have been thwarted…
Donald Trump has threatened to impose 50% tariffs on the EU, ranging from subsequent month,…
British taxpayers are set to swallow a lack of simply over £10bn on the 2008…
The funding agency which has agreed to purchase WH Smith's excessive avenue operations has been…